{"lastClose": 5.360000133514404, "len": 1117, "date": "2023-03-21", "alpha_1": -0.3561630738463354, "beta_1": 1.5516053418620497, "drawup_1": 1.5486725887776869, "natr_1": 15.655275790799333, "sup_1": -0.09266176396235085, "res_1": 0.5926616305191192, "bullPattern_1": [], "bearPattern_1": ["SHORTLINE"], "rsi_1": 22.374417044562087, "adx_1": 36.58879029636773, "drawdown_1": -0.6898148194139384, "stratHoldSharpe_1": -0.4012806774550999, "stratHoldAlpha_1": 250.72921599725655, "stratHoldDrawdown_1": -0.6501424223333698, "alpha_3mo": -0.32319351181694855, "beta_3mo": 1.6333869606926221, "drawup_3mo": 0.4608541290620036, "natr_3mo": 15.655275790799333, "sup_3mo": -0.12562191588598665, "res_3mo": 0.002487530100715648, "bullPattern_3mo": ["DOJI", "GRAVESTONEDOJI", "LONGLEGGEDDOJI"], "bearPattern_3mo": ["SPINNINGTOP"], "rsi_3mo": 12.307683278821054, "adx_3mo": 49.345917918016326, "drawdown_3mo": -0.34713762379906443, "stratHoldSharpe_3mo": -0.512841632346346, "stratHoldAlpha_3mo": 250.70161419306186, "stratHoldDrawdown_3mo": -0.32086563635642196, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Market Cap": 772966425, "Name": "Allogene Therapeutics Inc.", "IPO Year": 2018.0, "Sector": "Health Care", "Country": "United States", "alpha%_1": 0.15839089304969162, "beta%_1": 0.8802884935577047, "drawup%_1": 0.9976982333503427, "natr%_1": 0.9999975654074543, "drawdown%_1": 0.05572695757810548, "stratHoldSharpe%_1": 0.3229309481594216, "stratHoldAlpha%_1": 0.16856593459517877, "stratHoldDrawdown%_1": 0.043191537436158965, "alpha%_3mo": 0.2580677724509951, "beta%_3mo": 0.8566534635501173, "drawup%_3mo": 0.9103428345036548, "natr%_3mo": 0.9999962468193871, "drawdown%_3mo": 0.06988775743658707, "stratHoldSharpe%_3mo": 0.28375316777501314, "stratHoldAlpha%_3mo": 0.22867292353730745, "stratHoldDrawdown%_3mo": 0.06687962470701436}